These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1946 related articles for article (PubMed ID: 29686738)

  • 41. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma.
    Galamb O; Kalmár A; Barták BK; Patai ÁV; Leiszter K; Péterfia B; Wichmann B; Valcz G; Veres G; Tulassay Z; Molnár B
    World J Gastroenterol; 2016 Dec; 22(47):10325-10340. PubMed ID: 28058013
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Detection of mutations in circulating cell-free DNA in relation to disease stage in colorectal cancer.
    Liebs S; Keilholz U; Kehler I; Schweiger C; Haybäck J; Nonnenmacher A
    Cancer Med; 2019 Jul; 8(8):3761-3769. PubMed ID: 31134762
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hypermethylation and decreased expression of TMEM240 are potential early-onset biomarkers for colorectal cancer detection, poor prognosis, and early recurrence prediction.
    Chang SC; Liew PL; Ansar M; Lin SY; Wang SC; Hung CS; Chen JY; Jain S; Lin RK
    Clin Epigenetics; 2020 May; 12(1):67. PubMed ID: 32398064
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Novel methylation panel for the early detection of colorectal tumors in stool DNA.
    Azuara D; Rodriguez-Moranta F; de Oca J; Soriano-Izquierdo A; Mora J; Guardiola J; Biondo S; Blanco I; Peinado MA; Moreno V; Esteller M; Capellá G
    Clin Colorectal Cancer; 2010 Jul; 9(3):168-76. PubMed ID: 20643622
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Epigenetic alteration: new insights moving from tissue to plasma - the example of PCDH10 promoter methylation in colorectal cancer.
    Danese E; Minicozzi AM; Benati M; Montagnana M; Paviati E; Salvagno GL; Gusella M; Pasini F; Guidi GC; Lippi G
    Br J Cancer; 2013 Aug; 109(3):807-13. PubMed ID: 23839493
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Genome-wide analysis of DNA methylation in prostate cancer using the technology of Infinium HumanMethylation450 BeadChip (HM450)].
    Babalyan KA; Sultanov R; Generozov EV; Zakharzhevskaya NB; Sharova EI; Peshkov MN; Vasilev AO; Govorov AV; Pushkar DY; Prilepskaya EA; Danilenko SA; Babikova EA; Larin AK; Govorun VM
    Vopr Onkol; 2016; 62(1):122-32. PubMed ID: 30444590
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Multiplexed DNA Methylation Analysis in Colorectal Cancer Using Liquid Biopsy and Its Diagnostic and Predictive Value.
    Pulverer W; Kruusmaa K; Schönthaler S; Huber J; Bitenc M; Bachleitner-Hofmann T; Bhangu JS; Oehler R; Egger G; Weinhäusel A
    Curr Issues Mol Biol; 2021 Oct; 43(3):1419-1435. PubMed ID: 34698107
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical Relevance of Plasma DNA Methylation in Colorectal Cancer Patients Identified by Using a Genome-Wide High-Resolution Array.
    Lin PC; Lin JK; Lin CH; Lin HH; Yang SH; Jiang JK; Chen WS; Chou CC; Tsai SF; Chang SC
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1419-27. PubMed ID: 25472652
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prediction of methylation status using WGS data of plasma cfDNA for multi-cancer early detection (MCED).
    Cui P; Zhou X; Xu S; He W; Huang G; Xiong Y; Zhang C; Chang T; Feng M; Lai H; Pan Y
    Clin Epigenetics; 2024 Feb; 16(1):34. PubMed ID: 38414068
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comprehensive DNA methylation analysis of tissue of origin of plasma cell-free DNA by methylated CpG tandem amplification and sequencing (MCTA-Seq).
    Liu X; Ren J; Luo N; Guo H; Zheng Y; Li J; Tang F; Wen L; Peng J
    Clin Epigenetics; 2019 Jun; 11(1):93. PubMed ID: 31234922
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Longitudinal analysis of individual cfDNA methylome patterns in metastatic prostate cancer.
    Silva R; Moran B; Baird AM; O'Rourke CJ; Finn SP; McDermott R; Watson W; Gallagher WM; Brennan DJ; Perry AS
    Clin Epigenetics; 2021 Aug; 13(1):168. PubMed ID: 34454584
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Discovery and validation of methylation signatures in blood-based circulating tumor cell-free DNA in early detection of colorectal carcinoma: a case-control study.
    Sui J; Wu X; Wang C; Wang G; Li C; Zhao J; Zhang Y; Xiang J; Xu Y; Nian W; Cao F; Yu G; Lou Z; Hao L; Liu L; Li B; Zhang Z; Cai S; Liu H; Lan P; Zhang W
    Clin Epigenetics; 2021 Feb; 13(1):26. PubMed ID: 33536049
    [TBL] [Abstract][Full Text] [Related]  

  • 53. 5-Hydroxymethylcytosine signatures in circulating cell-free DNA as diagnostic biomarkers for human cancers.
    Li W; Zhang X; Lu X; You L; Song Y; Luo Z; Zhang J; Nie J; Zheng W; Xu D; Wang Y; Dong Y; Yu S; Hong J; Shi J; Hao H; Luo F; Hua L; Wang P; Qian X; Yuan F; Wei L; Cui M; Zhang T; Liao Q; Dai M; Liu Z; Chen G; Meckel K; Adhikari S; Jia G; Bissonnette MB; Zhang X; Zhao Y; Zhang W; He C; Liu J
    Cell Res; 2017 Oct; 27(10):1243-1257. PubMed ID: 28925386
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Circulating cell-free DNA in plasma of colorectal cancer patients - A potential biomarker for tumor burden.
    Bhangu JS; Taghizadeh H; Braunschmid T; Bachleitner-Hofmann T; Mannhalter C
    Surg Oncol; 2017 Dec; 26(4):395-401. PubMed ID: 29113658
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cell-Free DNA Methylation: The New Frontiers of Pancreatic Cancer Biomarkers' Discovery.
    Brancaccio M; Natale F; Falco G; Angrisano T
    Genes (Basel); 2019 Dec; 11(1):. PubMed ID: 31877923
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High-throughput and affordable genome-wide methylation profiling of circulating cell-free DNA by methylated DNA sequencing (MeD-seq) of LpnPI digested fragments.
    Deger T; Boers RG; de Weerd V; Angus L; van der Put MMJ; Boers JB; Azmani Z; van IJcken WFJ; Grünhagen DJ; van Dessel LF; Lolkema MPJK; Verhoef C; Sleijfer S; Martens JWM; Gribnau J; Wilting SM
    Clin Epigenetics; 2021 Oct; 13(1):196. PubMed ID: 34670587
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification of diagnostic markers in colorectal cancer via integrative epigenomics and genomics data.
    Kok-Sin T; Mokhtar NM; Ali Hassan NZ; Sagap I; Mohamed Rose I; Harun R; Jamal R
    Oncol Rep; 2015 Jul; 34(1):22-32. PubMed ID: 25997610
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 5-Hydroxymethylcytosine profiling from genomic and cell-free DNA for colorectal cancers patients.
    Gao P; Lin S; Cai M; Zhu Y; Song Y; Sui Y; Lin J; Liu J; Lu X; Zhong Y; Cui Y; Zhou P
    J Cell Mol Med; 2019 May; 23(5):3530-3537. PubMed ID: 30912288
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serum DNA methylome of the colorectal cancer serrated pathway enables non-invasive detection.
    Gallardo-Gómez M; Costas-Ríos L; Garcia-Prieto CA; Álvarez-Rodríguez L; Bujanda L; Barrero M; Castells A; Balaguer F; Jover R; Esteller M; Tardío Baiges A; González-Carreró Fojón J; Cubiella J; De Chiara L
    Mol Oncol; 2024 Nov; 18(11):2696-2713. PubMed ID: 38129291
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Colorectal Cancer Early Detection in Stool Samples Tracing CpG Islands Methylation Alterations Affecting Gene Expression.
    Vega-Benedetti AF; Loi E; Moi L; Orrù S; Ziranu P; Pretta A; Lai E; Puzzoni M; Ciccone L; Casadei-Gardini A; Cabras F; Fortunato F; Restivo A; Zorcolo L; Scartozzi M; Zavattari P
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32599859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 98.